- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Synonyms :
Class :
Indicated for constipation induced by opioids in patients with chronic non-cancerous pain
0.2 mg orally each day
Indicated for constipation induced by opioids in patients with chronic non-cancerous pain
0.2 mg orally each day
Dosage Modifications
In the case of hepatic impairment/ severe Child-Pugh C, avoid the usage of naldemedine
may have an increased Effect of CNS depressant when combined with opioid agonists
may have an increased Effect of CNS depressant when combined with opioid agonists
may have an increased Effect of CNS depressant when combined with opioid agonists
may increase the toxic effect of Opioid Antagonists
CYP3A strong enhancers of the small intestine may reduce the bioavailability of naldemedine enzal
opioid agonists increase the effect of constipation of eluxadoline
it decreases the effect of opioid agonists
they decrease the effect of analgesia of opioid agonists
they decrease the effect of analgesia of opioid agonists
they decrease the effect of analgesia of opioid agonists
it decreases the efficacy of opioid agonists
may increase the CNS depressant effect
may increase the adverse effect of Opioid Antagonists
It may enhance the effect when combined with grapefruit by CYP3A4 metabolism
naldemedine: they may diminish the serum concentration of CYP3A4 Inducers
naldemedine: they may diminish the serum concentration of CYP3A4 Inducers
naldemedine: they may diminish the serum concentration of CYP3A4 Inducers
naldemedine: they may diminish the serum concentration of CYP3A4 Inducers
naldemedine: they may diminish the serum concentration of CYP3A4 Inducers
it may diminish the excretion rate when combined with gadofosveset, resulting in an enhanced serum level
spironolactone and hydrochlorothiazide
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of loop diuretics
mu-opioid receptor agonists: they may increase the toxic effect of loop diuretics
mu-opioid receptor agonists: they may increase the toxic effect of loop diuretics
the effect of naldemedine is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
CYP3A4 inhibitors increase the concentration of naldemedine in serum
they increase the effect of analgesia of opioid agonists
they increase the effect of analgesia of opioid agonists
they increase the effect of analgesia of opioid agonists
they increase the effect of analgesia of opioid agonists
they increase the effect of analgesia of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
may decrease the serum concentration of CYP3A4 Inducers
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
amphetamines: they may increase the analgesic effect of mu-opioid receptor agonists
anticholinestereses: they may increase the toxic effect of mu-opioid receptor agonists
anticholinestereses: they may increase the toxic effect of mu-opioid receptor agonists
anticholinestereses: they may increase the toxic effect of mu-opioid receptor agonists
anticholinestereses: they may increase the toxic effect of mu-opioid receptor agonists
anticholinestereses: they may increase the toxic effect of mu-opioid receptor agonists
desmopressin acetate: they may increase the toxic effect of mu-opioid receptor agonist
pegvisomant: they may decrease the therapeutic effect of mu-opioid receptor agonists
ramosetron: they may increase the constipating effect of mu-opioid receptor agonists